Backed by extensive experience in venture capital, the fund manager has successfully executed over 70 deals across diverse sectors, including technology and healthcare. Active primarily in Europe and North America, they emphasize a thematic investment approach that prioritizes innovative startups at the early to growth stages. Their portfolio includes notable exits such as a leading software provider and a breakthrough biotech company, showcasing a strong track record of value creation. With a data-driven strategy, they aim to identify and nurture high-potential ventures that align with emerging market trends.